MZT1

MZT1 (MOZART1) is a small, evolutionarily conserved component of the γ-tubulin complex that governs the recruitment of γ-tubulin ring/small complexes to microtubule organizing centers (MTOCs) rather than the assembly of the complex core itself (PMID:23885124). It functions by directly binding the N-terminal domains of γ-tubulin complex protein (GCP) subunits—particularly GCP3—through an intercalative mode that allows promiscuous engagement of multiple GCPs and thereby controls γ-TuRC localization across different cell cycle stages (PMID:24006493, PMID:32610137). In vitro reconstitution shows MZT1 stabilizes the GCP3 homolog in an interaction-competent conformation within the γ-tubulin small complex, converting assembled subcomplexes into potent microtubule nucleators (PMID:31287970). Structurally, MZT1–GCP3 subcomplexes serve as anchoring modules that bridge the NEDD1 attachment factor to the γ-TuRC lumen [PMID:bio_10.1101_2024.11.05.622067]. MZT1 activity is also context-specific: it is required only at particular MTOCs in a tissue-restricted manner, as seen in Drosophila where it acts at basal bodies and centriole adjuncts in the testes (PMID:29983314), and it operates at the nuclear envelope in plants (PMID:24570680). In gastric cancer cells, MZT1 stabilizes NEDD1 by inhibiting its ubiquitination and supports proliferation, invasion, and glycolysis (PMID:40204068).

1. 2013 High

   Established that MZT1's essential role is attaching the γ-tubulin complex to MTOCs rather than building the complex, resolving where in the pathway it acts.

   Evidence Temperature-sensitive mzt1 mutants, localization microscopy, co-IP and stoichiometry in fission yeast

   PMID:23885124

   Open questions at the time

   • Molecular interaction surface mediating MTOC attachment not defined
   • Did not identify which GCP subunit MZT1 binds
2. 2013 High

   Identified the direct molecular partner, showing MZT1 binds the N-terminal region of GCP3, providing a physical basis for its role in the complex.

   Evidence Yeast two-hybrid, biophysical assays with recombinant proteins, co-IP in fission yeast

   PMID:24006493

   Open questions at the time

   • Binding mode and affinity not structurally resolved
   • Whether MZT1 binds only GCP3 or other GCPs unaddressed
3. 2017 Medium

   Characterized the human protein's solution behavior and confirmed the GCP3 N-terminal interaction is conserved in humans.

   Evidence NMR spectroscopy, SEC-MALS, dynamic light scattering with recombinant human proteins

   PMID:28851027

   Open questions at the time

   • No mutagenesis validation of interaction residues
   • Functional consequence of oligomerization unknown
4. 2018 High

   Revealed that MZT1 confers MTOC- and tissue-specific γ-TuRC heterogeneity, demonstrating it is not a universal core subunit but a selective recruitment factor.

   Evidence Drosophila mzt1 mutant analysis, live imaging, γ-TuRC localization in developing sperm

   PMID:29983314

   Open questions at the time

   • Molecular basis for MTOC selectivity not defined
   • Generalizability beyond testis-specific context unclear
5. 2019 High

   Defined the mechanism by which MZT1 enables nucleation, showing it stabilizes the GCP3 homolog in an interaction-competent conformation to make reconstituted complexes potent nucleators.

   Evidence In vitro reconstitution of microtubule nucleation with purified recombinant fission yeast components

   PMID:31287970

   Open questions at the time

   • Conformational change not directly visualized at atomic resolution
   • Reconstitution used fission yeast, not human, components
6. 2020 High

   Provided the structural basis showing MZT1 binds multiple GCP N-terminal domains via an intercalative mode, explaining how it controls γ-TuRC subcellular localization across cell cycle stages.

   Evidence X-ray crystallography of MZT1–GCP complexes plus genetic and fluorescence analysis in fission yeast

   PMID:32610137

   Open questions at the time

   • How promiscuous binding is regulated in time and space not resolved
   • Human structural confirmation absent
7. 2024 High

   Placed MZT1 within the human γ-TuRC architecture as a structural bridge anchoring the NEDD1 attachment factor to the complex lumen.

   Evidence Cryo-EM of NEDD1-bound human γ-TuRC, AlphaFold modeling, NEDD1 mutant pulldowns (preprint)

   PMID:bio_10.1101_2024.11.05.622067

   Open questions at the time

   • Preprint not yet peer-reviewed
   • Functional consequence of disrupting the MZT1–NEDD1 bridge in cells untested
8. 2025 Medium

   Extended MZT1 function into disease, showing it stabilizes NEDD1 by blocking ubiquitination and supports gastric cancer metabolism and proliferation.

   Evidence Knockdown experiments in vitro and in vivo, ubiquitination assay, proteomics in gastric cancer cells

   PMID:40204068

   Open questions at the time

   • Single-lab cancer context may not reflect canonical function
   • Mechanism linking MZT1 to ubiquitination machinery undefined

• How MZT1's promiscuous GCP binding is dynamically regulated to direct γ-TuRC to specific MTOCs at specific times, and whether this regulation is conserved in human cells, remains open.
• No regulatory mechanism (PTM, partner-driven) for MTOC selectivity established
• Human in-cell loss-of-function phenotypes not characterized in the corpus